Affiliated with RCfalse
Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy
Zhu,Yuefei1,2; Yu,Xiangrong3; Thamphiwatana,Soracha D.4; Zheng,Ying5; Pang,Zhiqing2
Source PublicationActa Pharmaceutica Sinica B

Cancer immunotherapy has veered the paradigm of cancer treatment. Despite recent advances in immunotherapy for improved antitumor efficacy, the complicated tumor microenvironment (TME) is highly immunosuppressive, yielding both astounding and unsatisfactory clinical successes. In this regard, clinical outcomes of currently available immunotherapy are confined to the varied immune systems owing in large part to the lack of understanding of the complexity and diversity of the immune context of the TME. Various advanced designs of nanomedicines could still not fully surmount the delivery barriers of the TME. The immunosuppressive TME may even dampen the efficacy of antitumor immunity. Recently, some nanotechnology-related strategies have been inaugurated to modulate the immunosuppressive cells within the tumor immune microenvironment (TIME) for robust immunotherapeutic responses. In this review, we will highlight the current understanding of the immunosuppressive TIME and identify disparate subclasses of TIME that possess an impact on immunotherapy, especially those unique classes associated with the immunosuppressive effect. The immunoregulatory cell types inside the immunosuppressive TIME will be delineated along with the existing and potential approaches for immunosuppressive cell modulation. After introducing the various strategies, we will ultimately outline both the novel therapeutic targets and the potential issues that affect the efficacy of TIME-based nanomedicines.

KeywordCancer Immunotherapy Drug Delivery Nanomedicine Tumor Immunosuppressive Microenvironment
URLView the original
Indexed BySCIE
WOS Research AreaPharmacology & Pharmacy
WOS SubjectPharmacology & Pharmacy
WOS IDWOS:000595499500004
Scopus ID2-s2.0-85090854667
Fulltext Access
Citation statistics
Cited Times [WOS]:26   [WOS Record]     [Related Records in WOS]
Document TypeJournal article
CollectionUniversity of Macau
Corresponding AuthorYu,Xiangrong; Pang,Zhiqing
Affiliation1.Department of Biomedical Engineering,Columbia University,New York,10027,United States
2.Key Laboratory of Smart Drug Delivery,School of Pharmacy,Fudan University,Ministry of Education,Shanghai,201203,China
3.Department of Medical Imaging,Zhuhai People's Hospital,Zhuhai Hospital Affiliated with Jinan University,Zhuhai,519000,China
4.Department of Biomedical Engineering,Faculty of Engineering,Mahidol University,Nakhon Pathom,73170,Thailand
5.State Key Laboratory of Quality Research in Chinese Medicine,Institute of Chinese Medical Sciences,University of Macau,999078,China
Recommended Citation
GB/T 7714
Zhu,Yuefei,Yu,Xiangrong,Thamphiwatana,Soracha D.,et al. Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy[J]. Acta Pharmaceutica Sinica B,2020,10(11):2054-2074.
APA Zhu,Yuefei,Yu,Xiangrong,Thamphiwatana,Soracha D.,Zheng,Ying,&Pang,Zhiqing.(2020).Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy.Acta Pharmaceutica Sinica B,10(11),2054-2074.
MLA Zhu,Yuefei,et al."Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy".Acta Pharmaceutica Sinica B 10.11(2020):2054-2074.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Zhu,Yuefei]'s Articles
[Yu,Xiangrong]'s Articles
[Thamphiwatana,Soracha D.]'s Articles
Baidu academic
Similar articles in Baidu academic
[Zhu,Yuefei]'s Articles
[Yu,Xiangrong]'s Articles
[Thamphiwatana,Soracha D.]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Zhu,Yuefei]'s Articles
[Yu,Xiangrong]'s Articles
[Thamphiwatana,Soracha D.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.